Michael Luebbert

3.6k total citations
9 papers, 33 citations indexed

About

Michael Luebbert is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Michael Luebbert has authored 9 papers receiving a total of 33 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Hematology, 3 papers in Genetics and 2 papers in Molecular Biology. Recurrent topics in Michael Luebbert's work include Acute Myeloid Leukemia Research (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Hematological disorders and diagnostics (2 papers). Michael Luebbert is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Hematological disorders and diagnostics (2 papers). Michael Luebbert collaborates with scholars based in Germany, Austria and United States. Michael Luebbert's co-authors include H. M. Kvasnicka, J. Thiele, Annette Schmitt‐Graeff, Volker Diehl, J. W. Vardiman, Lorenz Truemper, Christophe Ravoet, Peter Valent, Julie Schanz and Christa Fonatsch and has published in prestigious journals such as Blood, Annals of Hematology and Research Portal (King's College London).

In The Last Decade

Michael Luebbert

8 papers receiving 33 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Luebbert Germany	4	29	16	9	7	5	9	33
Tadbir K. Bariana United Kingdom	3	34 1.2×	10 0.6×	3 0.3×	5 0.7×	3 0.6×	5	47
R Mataix Spain	3	24 0.8×	8 0.5×	10 1.1×	7 1.0×	6 1.2×	8	34
Frédéric Millot France	3	18 0.6×	7 0.4×	7 0.8×	12 1.7×	2 0.4×	9	38
Georgia Andrew United States	4	40 1.4×	9 0.6×	9 1.0×	12 1.7×	2 0.4×	5	42
Laurent Garderet France	2	43 1.5×	25 1.6×	5 0.6×	10 1.4×	2 0.4×	4	47
Mario Petrini Italy	2	18 0.6×	8 0.5×	7 0.8×	10 1.4×	10 2.0×	2	29
Maria Creignou Sweden	4	15 0.5×	12 0.8×	4 0.4×	4 0.6×	3 0.6×	12	23
Émilie Lemasle France	4	53 1.8×	17 1.1×	11 1.2×	27 3.9×	4 0.8×	9	62
Nguyen Tan Binh Vietnam	4	14 0.5×	15 0.9×	5 0.6×	9 1.3×	2 0.4×	7	24
Antonella La Brocca Italy	2	15 0.5×	11 0.7×	4 0.4×	12 1.7×	2 0.4×	3	23

Countries citing papers authored by Michael Luebbert

Since Specialization

Citations

This map shows the geographic impact of Michael Luebbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Luebbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Luebbert more than expected).

Fields of papers citing papers by Michael Luebbert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Luebbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Luebbert. The network helps show where Michael Luebbert may publish in the future.

Co-authorship network of co-authors of Michael Luebbert

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Luebbert. A scholar is included among the top collaborators of Michael Luebbert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Luebbert. Michael Luebbert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Schlenk, Richard F., Karina Eiwen, Jan Engelmann, et al.. (2011). Deregulated Expression of EVI1 Defines a Poor Prognostic Subset of MLL-Rearranged Acute Myeloid Leukemias. Blood. 118(21). 1441–1441.

Szende, Ágota, Caroline Schaefer, Thomas F. Goss, et al.. (2009). Valuation of transfusion-free living in MDS: results of health utility interviews with patients. Research Portal (King's College London). 7. 81. 1 indexed citations

Schanz, Julie, Marilyn L. Slovak, Kazuma Ohyashiki, et al.. (2008). New Prognostic Data on Rare Cytogenetic Abnormalities in MDS: A Collaborative Study of the International Working Group on MDS Cytogenetics. Blood. 112(11). 2688–2688. 1 indexed citations

Bennett, Kristi L., Romulo Martin Brena, Jinmai Jiang, et al.. (2007). Dual Epigenetic Control of CCAAT/Enhancer Binding Protein α (C/EBPα) Expression in Acute Myeloid Leukemia.. Blood. 110(11). 2116–2116. 1 indexed citations

Haase, Detlef, Ulrich Germing, Julie Schanz, et al.. (2006). Evidence for an Underestimation of the Prognostic Impact of Poor Cytogenetics within the IPSS.. Blood. 108(11). 252–252. 7 indexed citations

Haase, Detlef, Ulrich Germing, Julie Schanz, et al.. (2006). New and Comprehensive Cytogenetic Prognostication and Categorization in MDS.. Blood. 108(11). 248–248. 6 indexed citations

Steidl, Christian, Ulrich Germing, Barbara Hildebrandt, et al.. (2005). Sequential Cytogenetic Analyses of 577 Patients with Myelodysplastic Syndromes: Correlations between Initial Karyotype, Cytogenetic Dynamics, and Clinical Course.. Blood. 106(11). 2531–2531. 1 indexed citations

Thiele, J., H. M. Kvasnicka, J. W. Vardiman, et al.. (2004). Acute panmyelosis with myelofibrosis: a clinicopathological study on 46 patients including histochemistry of bone marrow biopsies and follow-up. Annals of Hematology. 83(8). 513–21. 12 indexed citations

Wijermans, P., Augustin Ferrant, Michael Luebbert, et al.. (1999). DNA demethylating therapy in MDS: The experience with 5-AZA-2 '-deoxycytidine (decitabine).. Blood. 94(10). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact